Skip to main content
. Author manuscript; available in PMC: 2012 Feb 24.
Published in final edited form as: Vaccine. 2011 Jan 14;29(10):1891–1898. doi: 10.1016/j.vaccine.2010.12.134

Figure 3.

Figure 3

Reactivity of immune sera to GalXM as detected by GalXM ELISA using Nunc Covalink NH plates with varying concentrations of reacting GalXM. (A) GalXM-BSA immune sera (circle) but not the control sera (square) revealed antibody response to GalXM covalently coated to the plate. (B) Inhibition ELISA using various concentrations of free GalXM confirmed the specificity of antibody response to GalXM.